GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Notes Receivable

Helixmith Co (XKRX:084990) Notes Receivable : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Helixmith Co Notes Receivable?

Helixmith Co's Notes Receivable for the quarter that ended in Dec. 2024 was ₩0 Mil.


Helixmith Co Notes Receivable Historical Data

The historical data trend for Helixmith Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helixmith Co Notes Receivable Chart

Helixmith Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Helixmith Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Helixmith Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Helixmith Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of Helixmith Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Helixmith Co Business Description

Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 5th Floor, Building Number 203, Seoul National University, Seoul, KOR, 08826
Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Helixmith Co Headlines

No Headlines